207_Combined course Presentations

Efficacy of Chemo-Radiotherapy in Stage III Non-Small Cell Lung Cancer and PD-L1 expression J Adam, A. Boros, B. Lacas, L. Lacroix, J.-P. Pignon, C. Caramella, D. Planchard, A. Levy, B. Besse, C. Le Pechoux

Progression free survival (PFS)

Overall survival (OS)

PD-L1 -

PD-L1 -

Median OS: 2 years

Median PFS: 1 year

PD-L1 +

Median OS: 1.1 years

Median PFS: 0.7 year

PD-L1 +